Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.781
AS - Asia 5.728
EU - Europa 5.059
SA - Sud America 878
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 19
Totale 22.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.507
SG - Singapore 2.164
CN - Cina 1.391
IT - Italia 1.069
RU - Federazione Russa 741
DE - Germania 678
HK - Hong Kong 664
SE - Svezia 650
BR - Brasile 641
VN - Vietnam 639
IE - Irlanda 474
UA - Ucraina 440
GB - Regno Unito 283
FR - Francia 220
IN - India 212
CA - Canada 206
FI - Finlandia 140
ZA - Sudafrica 108
BD - Bangladesh 91
TR - Turchia 87
AR - Argentina 78
NL - Olanda 74
IQ - Iraq 64
AT - Austria 63
KR - Corea 63
DK - Danimarca 54
MX - Messico 48
JP - Giappone 47
PK - Pakistan 41
EC - Ecuador 40
CO - Colombia 36
ES - Italia 34
ID - Indonesia 34
PL - Polonia 33
SA - Arabia Saudita 30
MA - Marocco 27
VE - Venezuela 27
PH - Filippine 26
BE - Belgio 22
CL - Cile 21
EG - Egitto 18
IR - Iran 18
MY - Malesia 17
AE - Emirati Arabi Uniti 16
EU - Europa 16
KE - Kenya 15
ET - Etiopia 14
PY - Paraguay 14
TN - Tunisia 14
UZ - Uzbekistan 14
DZ - Algeria 13
JO - Giordania 13
AU - Australia 12
NP - Nepal 11
TH - Thailandia 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
GR - Grecia 10
IL - Israele 10
PE - Perù 10
CH - Svizzera 9
LB - Libano 9
RO - Romania 8
NO - Norvegia 7
CR - Costa Rica 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
OM - Oman 6
PS - Palestinian Territory 6
TW - Taiwan 6
UY - Uruguay 6
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
MD - Moldavia 5
A1 - Anonimo 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
ZM - Zambia 4
AO - Angola 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
QA - Qatar 2
RE - Reunion 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 22.698
Salva come PNG Salva come JPEG
Città #
Singapore 1.264
Woodbridge 978
Ann Arbor 953
Ashburn 923
Houston 718
Fairfield 661
Hong Kong 648
Chandler 605
San Jose 497
Dublin 450
Jacksonville 450
Dearborn 369
New York 327
Frankfurt am Main 319
Wilmington 315
Milan 282
Seattle 269
Cambridge 257
Santa Clara 241
Beijing 213
Princeton 199
Dallas 163
The Dalles 152
Chicago 151
Hanoi 144
Ho Chi Minh City 138
Nanjing 138
Los Angeles 126
Shanghai 115
Altamura 95
Lauterbourg 90
Lawrence 82
Lachine 81
Council Bluffs 77
São Paulo 71
Moscow 67
Cape Town 60
Hefei 59
Nanchang 58
Guangzhou 56
Buffalo 55
Dong Ket 55
Vienna 55
Columbus 54
San Diego 50
Helsinki 48
Shenyang 46
Orem 45
Rome 45
Seoul 40
Andover 39
Hebei 37
Ottawa 37
Tianjin 34
Munich 33
Tokyo 31
Jinan 30
Jiaxing 28
Changsha 27
Toronto 27
Warsaw 27
Baghdad 26
Boardman 26
Manchester 26
Boston 24
Da Nang 24
Zhengzhou 24
Hangzhou 23
Lissone 22
Mountain View 22
Fremont 21
Haiphong 21
London 21
Istanbul 20
Johannesburg 20
Chennai 19
Bologna 18
Montreal 18
Brooklyn 17
Dhaka 17
Mumbai 16
Phoenix 16
Nairobi 15
Rio de Janeiro 15
Salt Lake City 15
San Francisco 15
Brussels 14
Guayaquil 14
Huizen 14
Hải Dương 14
Ningbo 14
Nürnberg 14
Biên Hòa 13
Kunming 13
Lahore 13
Medellín 13
New Delhi 13
Norwalk 13
Pune 13
Valencia 13
Totale 14.393
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 446
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 376
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 335
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 324
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 323
Health related quality of life in chronic liver diseases 313
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 308
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 300
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 298
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 297
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 296
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 295
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 290
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 289
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 288
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 287
The impact of liver disease on the health-related quality of life 284
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 279
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 277
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 275
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 273
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 272
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 271
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 270
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 269
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 267
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 266
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 264
Health Related Quality of Life in the Major Liver Conditions 263
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 260
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 260
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 258
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 253
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 249
Difference in health related quality of life of chronic liver diseases and general population 248
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 247
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 246
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 246
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 246
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 245
Incidence of pain after craniotomy in children 243
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: A systematic review and meta-analysis 242
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 241
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 240
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 239
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 238
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 238
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 237
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 236
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 234
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 232
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 232
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 229
Light alcohol drinking and cancer: a meta-analysis 229
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 229
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 228
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 228
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 228
A meta-analysis on alcohol drinking and gastric cancer risk 225
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 224
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 223
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 218
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 218
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 218
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 217
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 217
Donor safety in living donor liver donation: An Italian multicenter survey 213
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 213
Re: light drinking has positive public health consequences 212
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 211
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 210
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 209
Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation 207
Is multifocality a prognostic factor in childhood hepatoblastoma? 206
A meta-analysis of alcohol consumption and the risk of brain tumours 202
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 200
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 199
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 196
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 195
A random-effects meta-regression model for studying nonlinear dose-response relationship 195
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 185
Cut-pont finding methods for continuous biomarkers 177
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 176
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 173
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 172
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 171
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 167
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 165
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 164
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 164
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 163
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 158
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 154
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 154
Cut-point identification in biomarkers for a censored failure time outcome 150
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 150
Cut-point identification in biomarkers for a censored failure time outcome 145
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 140
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 131
Totale 23.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 0 0 0 144 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20253.163 227 363 185 127 286 134 164 134 372 448 226 497
2025/20266.872 803 358 586 703 1.009 443 1.078 417 703 772 0 0
Totale 23.263